Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
शेयरों में रैंक #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
शेयर मूल्य
$0.11725176
अंतिम समन्वयन: 2025-07-14
मार्केट कैप
$481.50K
बदलाव (1 दिन)
-0.20%
बदलाव (1 वर्ष)
0.00%
देश
FR
व्यापार PHAXIAM Therapeutics S.A. (PHXM)

श्रेणी

PHAXIAM Therapeutics S.A. (PHXM) के लिए EPS
June 2024 TTM तक का EPS: $-4.23
PHAXIAM Therapeutics S.A. की नवीनतम वित्तीय रिपोर्टों और शेयर मूल्य के अनुसार, कंपनी का वर्तमान EPS (TTM) $-4.23 है। 2022 के अंत में, कंपनी का EPS $-0.07 था, जो 2021 के EPS $-23.87 के की तुलना में कमी था।
PHAXIAM Therapeutics S.A. के लिए 2016 से 2026 तक का EPS इतिहास
प्रत्येक वर्ष के अंत में EPS
वर्ष EPS परिवर्तन
2026 (TTM) $-4.23 -23.50%
2023 $-5.53 7,492.45%
2022 $-0.07 -99.69%
2021 $-23.87 -46.82%
2020 $-44.88 23.87%
2019 $-36.23 60.03%
2018 $-22.64 -30.76%
2017 $-32.70 21.96%
2016 $-26.81 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए EPS
कंपनी EPS EPS अंतर देश
$17.32 -509.44%
US
$27.74 -755.76%
NL
- -
CH
- -
KR
$13.70 -423.86%
BE